News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
ROBIN HOWARD W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 19,998 shares
@ $0.78, valued at
$15.6k
|
|
| 05/17/2023 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 20,361 shares
@ $0.72, valued at
$14.7k
|
|
| 11/18/2022 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 38,014 shares
@ $3.57, valued at
$135.7k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 12,480 shares
@ $10.95, valued at
$136.7k
|
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 94,100 shares
@ $0
Sold 42,773 shares
@ $13.16, valued at
$562.9k
|
|
| 10/14/2021 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 167,650 options to buy
@ $21.79, valued at
$3.7M
|
|
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 106,650 shares
@ $0
Granted 190,650 options
@ $18.75, valued at
$3.6M
|
|
| 11/18/2020 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 11,975 shares
@ $16.93, valued at
$202.7k
|
|
| 08/19/2020 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 11,885 shares
@ $19.67, valued at
$233.8k
|
|
| 05/20/2020 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 8,968 shares
@ $22.51, valued at
$201.9k
|
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 94,100 shares
@ $0
Granted 167,650 options
@ $21.79, valued at
$3.7M
Granted 44,600 options
@ $21.79, valued at
$971.8k
|
|
| 11/20/2019 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 13,556 shares
@ $17.97, valued at
$243.6k
|
|
| 10/17/2019 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 8,833 shares
@ $16.35, valued at
$144.4k
Sold 24,500 shares
@ $17.17, valued at
$420.7k
Sold 33,334 shares
@ $17.48, valued at
$582.7k
Sold 33,333 shares
@ $17.68, valued at
$589.3k
Exercised 33,333 options to buy
@ $7.21, valued at
$240.3k
Exercised 33,334 options to buy
@ $7.21, valued at
$240.3k
Exercised 33,333 options to buy
@ $7.21, valued at
$240.3k
|
|
| 08/26/2019 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Exercised 30,000 options to buy
@ $16.31, valued at
$489.3k
|
|
| 08/19/2019 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 12,551 shares
@ $18.15, valued at
$227.8k
|
|
| 07/25/2019 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 33,333 shares
@ $32.1, valued at
$1.1M
Sold 33,334 shares
@ $32.11, valued at
$1.1M
Sold 33,333 shares
@ $29.65, valued at
$988.3k
Exercised 33,333 options to buy
@ $7.21, valued at
$240.3k
Exercised 33,334 options to buy
@ $7.21, valued at
$240.3k
Exercised 33,333 options to buy
@ $7.21, valued at
$240.3k
|
|
| 05/23/2019 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 33,333 shares
@ $32.93, valued at
$1.1M
Sold 33,334 shares
@ $33.38, valued at
$1.1M
Sold 33,333 shares
@ $32.69, valued at
$1.1M
Exercised 33,333 options to buy
@ $7.21, valued at
$240.3k
Exercised 33,334 options to buy
@ $7.21, valued at
$240.3k
Exercised 33,333 options to buy
@ $7.21, valued at
$240.3k
|
|
| 05/17/2019 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 13,383 shares
@ $31.37, valued at
$419.8k
|
|
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2018 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 68,450 shares
@ $0
Granted 138,350 options
@ $36.51, valued at
$5.1M
|
|
| 11/19/2018 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 15,326 shares
@ $38.25, valued at
$586.2k
|
|
| 08/16/2018 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 40,000 shares
@ $10.69, valued at
$427.6k
Disposed/sold 40,000 shares
@ $60.08, valued at
$2.4M
Granted 60,500 shares
@ $0
Disposed/sold 20,389 shares
@ $58.4, valued at
$1.2M
Exercised 40,000 options to buy
@ $10.69, valued at
$427.6k
Granted 151,250 options to buy
@ $56.9, valued at
$8.6M
|
|
| 06/27/2018 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 43,334 shares
@ $51.82, valued at
$2.2M
Sold 43,333 shares
@ $49.36, valued at
$2.1M
Sold 43,333 shares
@ $47.39, valued at
$2.1M
Exercised 43,334 options to buy
@ $10.69, valued at
$463.2k
Exercised 43,333 options to buy
@ $10.69, valued at
$463.2k
Exercised 43,333 options to buy
@ $10.69, valued at
$463.2k
|
|
| 05/18/2018 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 12,791 shares
@ $83.39, valued at
$1.1M
|
|
| 05/03/2018 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 43,334 shares
@ $83.65, valued at
$3.6M
Sold 43,333 shares
@ $85.63, valued at
$3.7M
Sold 43,333 shares
@ $82.86, valued at
$3.6M
Exercised 43,334 options to buy
@ $10.69, valued at
$463.2k
Exercised 43,333 options to buy
@ $10.69, valued at
$463.2k
Exercised 43,333 options to buy
@ $10.69, valued at
$463.2k
|
|
| 02/20/2018 |
4
| ROBIN HOWARD W (President & CEO) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 12,788 shares
@ $82.94, valued at
$1.1M
|
|
|
|
|